StockDuty ← Dashboard Aug 10, 2026 03:44 PM ET
CatalystFDA/Bio

SIONNA THERAPEUTICS, INC. (SION) DISCUSSES CLINICAL TRIAL RESULTS AND DISCONTINUATION OF 719 PROGRAM IN CYSTIC FIBROSIS TRANSCRIPT - SEEKINGALPHA

Clinical trial results plus discontinuation of 719 program signal material pipeline shift.

What changed
Why it matters
Clinical trial results plus discontinuation of 719 program signal material pipeline shift.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →